<DOC>
	<DOCNO>NCT00157131</DOCNO>
	<brief_summary>The primary objective study evaluate skin graft adherence wound heal burn patient evaluate whether FS 4IU VH S/D equivalent superior current standard care ( staple ) . The primary endpoint achievement complete ( 100 % ) wound closure within 28 day .</brief_summary>
	<brief_title>Safety Efficacy Study FS 4 IU VH S/D ( Fibrin Sealant With 4IU/mL Thrombin , Vapor Heated , Solvent/Detergent Treated ) Adhere Split Thickness Skin Grafts Improve Wound Healing Burn Patients</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Thrombin</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>Subjects legal representative , read , understood sign write informed consent . Subjects either sex . Female subject childbearing potential negative urine serum pregnancy test admission . Subjects &lt; = 65 year age include pediatric subject age . Subjects total burn wound measure &lt; = 40 % TBSA . Subjects contiguous deep partial thickness/full thickness wound , 2 % 8 % TBSA two comparable , bilateral wound measure 1 % 4 % TBSA . Wounds designated test site require autologous sheet skin graft thickness 8/1000 '' 16/1000 '' Subjects able , willing comply procedure require protocol . Subjects electrical burn . Subjects chemical burn Digits genitalia exclude test site . Subjects infection test area/test site . Subjects test sit previously randomize treat study . Subjects venous arterial vascular disorder directly affect designate test area/test site . Subjects preexist hemolytic anemia Subjects diabetes mellitus . Subjects document history pathologically pharmacologically induce immune deficiency . Subjects judge chronically malnourish . Subjects judge significant pulmonary compromise . Subjects receive systemic corticosteroid within 30 day prior skin graft ( include inhale steroid ) . Subjects know suspected hypersensitivity bovine protein . Subjects participate another clinical trial evaluate unapproved drug device .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>autologous sheet skin graft</keyword>
	<keyword>FS 4IU VH S/D</keyword>
	<keyword>skin graft</keyword>
	<keyword>burn</keyword>
</DOC>